|
1
|
Engholm G, Ferlay J, Christensen N, Bray
F, Gjerstorff ML, Klint A, Køtlum JE, Olafsdóttir E, Pukkala E and
Storm HH: NORDCAN - a Nordic tool for cancer information, planning,
quality control and research. Acta Oncol. 49:725–736. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Haapaniemi A, Koivunen P, Saarilahti K,
Kinnunen I, Laranne J, Aaltonen LM, Närkiö M, Lindholm P, Grénman
R, Mäkitie A, et al: Finnish Head and Neck Oncology Working Group:
Laryngeal cancer in Finland: A 5-year follow-up study of 366
patients. Head Neck. 38:36–43. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wennerberg J: A population based
perspective on treatment and outcome of glottic laryngeal carcinoma
stage T3 and T4 - does organ preservation jeopardize survival?5th
World Congress of IFHNOS and the 2014 Annual Meeting of the AHNS.
New York: 2014
|
|
4
|
Hoffman HT, Porter K, Karnell LH, Cooper
JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A and Robinson RA:
Laryngeal cancer in the United States: Changes in demographics,
patterns of care, and survival. Laryngoscope. 116 Suppl 111:1–13.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Olsen KD: Reexamining the treatment of
advanced laryngeal cancer. Head Neck. 32:1–7. 2010.PubMed/NCBI
|
|
6
|
Farnebo L, Tiefenbock K, Ansell A, Thunell
LK, Garvin S and Roberg K: Strong expression of survivin is
associated with positive response to radiotherapy and improved
overall survival in head and neck squamous cell carcinoma patients.
Int J Cancer. 133:1994–2003. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Garvin S, Tiefenböck K, Farnebo L, Thunell
LK, Farnebo M and Roberg K: Nuclear expression of WRAP53β is
associated with a positive response to radiotherapy and improved
overall survival in patients with head and neck squamous cell
carcinoma. Oral Oncol. 51:24–30. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Garg H, Suri P, Gupta JC, Talwar GP and
Dubey S: Survivin: A unique target for tumor therapy. Cancer Cell
Int. 16:492016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Altieri DC: Targeting survivin in cancer.
Cancer Lett. 332:225–228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li F, Yang J, Ramnath N, Javle MM and Tan
D: Nuclear or cytoplasmic expression of survivin: what is the
significance? Int J Cancer. 114:509–512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stauber RH, Mann W and Knauer SK: Nuclear
and cytoplasmic survivin: Molecular mechanism, prognostic, and
therapeutic potential. Cancer Res. 67:5999–6002. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lo Muzio L, Farina A, Rubini C, Pezzetti
F, Stabellini G, Laino G, Santarelli A, Pannone G, Bufo P, de Lillo
A, et al: Survivin as prognostic factor in squamous cell carcinoma
of the oral cavity. Cancer Lett. 225:27–33. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Freier K, Pungs S, Sticht C,
Flechtenmacher C, Lichter P, Joos S and Hofele C: High survivin
expression is associated with favorable outcome in advanced primary
oral squamous cell carcinoma after radiation therapy. Int J Cancer.
120:942–946. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mahmoudi S, Henriksson S, Corcoran M,
Méndez-Vidal C, Wiman KG and Farnebo M: Wrap53, a natural p53
antisense transcript required for p53 induction upon DNA damage.
Mol Cell. 33:462–471. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Henriksson S and Farnebo M: On the road
with WRAP53β: Guardian of Cajal bodies and genome integrity. Front
Genet. 6:912015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hedström E, Pederiva C, Farnebo J, Nodin
B, Jirström K, Brennan DJ and Farnebo M: Downregulation of the
cancer susceptibility protein WRAP53β in epithelial ovarian cancer
leads to defective DNA repair and poor clinical outcome. Cell Death
Dis. 6:e18922015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Silwal-Pandit L, Russnes H, Borgen E,
Skarpeteig V, Vollan Moen HK, Schlichting E, Kåresen R, Naume B,
Børresen-Dale AL, Farnebo M, et al: The sub-cellular Localization
of WRAP53 has prognostic impact in breast cancer. PLoS One.
10:e01399652015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rassoolzadeh H, Böhm S, Hedström E, Gad H,
Helleday T, Henriksson S and Farnebo M: Overexpression of the
scaffold WD40 protein WRAP53β enhances the repair of and cell
survival from DNA double-strand breaks. Cell Death Dis.
7:e22672016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fischer CA, Zlobec I, Green E, Probst S,
Storck C, Lugli A, Tornillo L, Wolfensberger M and Terracciano LM:
Is the improved prognosis of p16 positive oropharyngeal squamous
cell carcinoma dependent of the treatment modality? Int J Cancer.
126:1256–1262. 2010.PubMed/NCBI
|
|
20
|
Castellsagué X, Alemany L, Quer M, Halec
G, Quirós B, Tous S, Clavero O, Alòs L, Biegner T, Szafarowski T,
et al: ICO International HPV in Head and Neck Cancer Study Group:
HPV involvement in head and neck cancers: Comprehensive assessment
of biomarkers in 3680 patients. J Natl Cancer Inst. 108:djv4032016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Young RJ, Urban D, Angel C, Corry J, Lyons
B, Vallance N, Kleid S, Iseli TA, Solomon B and Rischin D:
Frequency and prognostic significance of p16INK4A
protein overexpression and transcriptionally active human
papillomavirus infection in laryngeal squamous cell carcinoma. Br J
Cancer. 112:1098–1104. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Morshed K, Polz-Dacewicz M, Szymański M
and Polz D: Short-fragment PCR assay for highly sensitive
broad-spectrum detection of human papillomaviruses in laryngeal
squamous cell carcinoma and normal mucosa: Clinico-pathological
evaluation. Eur Arch Otorhinolaryngol. 265 Suppl 1:S89–S96. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rischin D, Young RJ, Fisher R, Fox SB, Le
QT, Peters LJ, Solomon B, Choi J, OSullivan B, Kenny LM, et al:
Prognostic significance of p16INK4A and human papillomavirus in
patients with oropharyngeal cancer treated on TROG 02.02 phase III
trial. J Clin Oncol. 28:4142–4148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Forastiere AA, Goepfert H, Maor M, Pajak
TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, et
al: Concurrent chemotherapy and radiotherapy for organ preservation
in advanced laryngeal cancer. N Engl J Med. 349:2091–2098. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nishimura G, Tsukuda M, Mikami Y, Matsuda
H, Horiuchi C, Taguchi T, Takahashi M, Kawakami M, Watanabe M, Niho
T, et al: Efficacy of concurrent chemoradiotherapy for T1 and T2
laryngeal squamous cell carcinoma regarding organ preservation.
Anticancer Res. 29:661–666. 2009.PubMed/NCBI
|
|
26
|
Akimoto T, Nonaka T, Kitamoto Y, Ishikawa
H, Ninomiya H, Chikamatsu K, Furuya N, Hayakawa K, Mitsuhashi N and
Nakano T: Radiation therapy for T2N0 laryngeal cancer: A
retrospective analysis for the impact of concurrent chemotherapy on
local control. Int J Radiat Oncol Biol Phys. 64:995–1001. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Berardinelli F, Nieri D, Sgura A,
Tanzarella C and Antoccia A: Telomere loss, not average telomere
length, confers radiosensitivity to TK6-irradiated cells. Mutat
Res. 740:13–20. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
McCaul JA, Gordon KE, Minty F, Fleming J
and Parkinson EK: Telomere dysfunction is related to the intrinsic
radio-resistance of human oral cancer cells. Oral Oncol.
44:261–269. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Henriksson S, Rassoolzadeh H, Hedström E,
Coucoravas C, Julner A, Goldstein M, Imreh G, Zhivotovsky B, Kastan
MB, Helleday T, et al: The scaffold protein WRAP53beta orchestrates
the ubiquitin response critical for DNA double-strand break repair.
Genes Dev. 28:2726–2738. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kalfert D, Celakovsky P, Laco J and
Ludvikova M: The role of protein p16INK4a in glottic
laryngeal squamous cell carcinoma. Pathol Oncol Res. 20:909–915.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Baumann JL, Cohen S, Evjen AN, Law JH,
Vadivelu S, Attia A, Schindler JS, Chung CH, Wirth PS, Meijer CJ,
et al: Human papillomavirus in early laryngeal carcinoma.
Laryngoscope. 119:1531–1537. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jouhi L, Hagström J, Atula T and Mäkitie
A: Is p16 an adequate surrogate for human papillomavirus status
determination? Curr Opin Otolaryngol Head Neck Surg. 25:108–112.
2017. View Article : Google Scholar : PubMed/NCBI
|
